TG Therapeutics (0VGI) Hedge Fund Trading Activity
Trend: â–˛ Hedge Funds Increased Holdings by 178.4K Shares Last Quarter
Hedge Fund Holdings in 0VGI
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity​
Activity
Star Ranking
| Follow | |||||||
|---|---|---|---|---|---|---|---|
 Ray Dalio | Bridgewater Associates, LP | Added | 37.32% | $14,006,377 | 0.05% | ||
 Joel Greenblatt | Gotham Asset Management LLC | Not Changed | 0.00% | $1,518,789 | 0.01% | ||
 Andrew Law | Caxton Associates LP | Not Changed | 0.00% | $493,564 | 0.02% | ||
 Travis Knapp Anderson | Gilder Gagnon Howe & Co LLC. | Reduced | -71.42% | $607,915 | <0.01% | ||
 John Hussman | Hussman Strategic Advisors Inc | Sold Out | -100.00% | ― | 0.00% |
FAQ
Which hedge funds hold TG Therapeutics?
The hedge funds that hold the most shares in TG Therapeutics are Ray Dalio, Joel Greenblatt and Travis Knapp Anderson.
Are hedge funds buying or selling GB:0VGI?
In the last quarter hedge funds have Increased their holdings in TG Therapeutics by 178.4K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in TG Therapeutics stock?
Warren Buffet currently does not own shares in TG Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
